Age‐Related Decrease in Pellino‐1 Expression Contributes to Osteoclast‐Mediated Bone Loss
Advanced Biology · 2024
DOI: 10.1002/adbi.202400210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Dong Suk Yoon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Hwasung Medi-Science University, Hwasung, Gyeonggi-Do, 18274, South Korea. Hauptthemen laut MEDLINE: Osteoclasts, Bone Resorption, Ubiquitin-Protein Ligases, Mice, Knockout. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Faculty Research Grant.
Abstract (Originalsprache)
Aging‐related bone loss is driven by various biological factors, such as imbalanced bone metabolism from decreased osteoblast and increased osteoclast activities. Various transcriptional and post‐transcriptional factors increase osteoclast activity with aging; however, studies regarding the post‐translational regulators of osteoclast activity are still limited. The ubiquitin E3 ligase Pellino‐1 is a well‐known post‐translational regulator of inflammation. However, how Pellino‐1 expression regulation affects osteoclast differentiation remains unclear. This study determined that Pellino‐1 levels are reduced in bone marrow monocytes (BMMs) from 40‐week‐old mice compared to 4‐week‐old mice. Interestingly, conditional Knockout (cKO) of Pellino‐1 in 6‐week‐old mice resulted in decreased bone mass, reduced body size, and lower weight than in Pellino‐1 floxed mice; however, these differences are not observed in 20‐week‐old mice. The increased number of tartrate‐resistant acid phosphatase (TRAP)‐positive cells and serum levels of C‐terminal telopeptides of type I collagen, a marker of bone resorption, in 6‐week‐old Pellino‐1 cKO mice implied a connection between Pellino‐1 and the osteoclast population. Enhanced TRAP activity and upregulation of osteoclast genes in BMMs from the cKO mice indicate that Pellino‐1 deletion affects osteoclast differentiation, leading to decreased bone mass and heightened osteoclast activity. Thus, targeting Pellino‐1 could be a potential gene therapy for managing and preventing osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, Hwasung Medi-Science University, Hwasung, Gyeonggi-Do, 18274, South Korea.
- Stem Cell and Aging Laboratory, Institute of HSMU Medi-Science, Hwasung Medi-Science University, Hwaseong, Gyeonggi-Do, 18274, South Korea.
- Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea.
- Department of Orthopaedic Surgery, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, South Korea.
- Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, 03722, South Korea.
- Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, 03722, South Korea.
ORCID-Profile: Jin Woo Lee
Förderung
- National Research Foundation of Korea
- Faculty Research Grant
Zitieren
APA
Yoon, D. S., Oh, S. E., Lee, K. M., Jung, S., Ko, E. A., Kim, T. G., Park, K. H., & Lee, J. W. (2024). Age‐Related Decrease in Pellino‐1 Expression Contributes to Osteoclast‐Mediated Bone Loss. Advanced Biology. https://doi.org/10.1002/adbi.202400210
Vancouver
Yoon DS, Oh SE, Lee KM, Jung S, Ko EA, Kim TG, et al. Age‐Related Decrease in Pellino‐1 Expression Contributes to Osteoclast‐Mediated Bone Loss. Advanced Biology. 2024. doi:10.1002/adbi.202400210
BibTeX
@article{Yoon2024,
author = {Yoon, Dong Suk and Oh, Seung Eun and Lee, Kyoung-Mi and Jung, Sujin and Ko, Eun Ae and Kim, Tae-Gyun and Park, Kwang Hwan and Lee, Jin Woo},
title = {Age‐Related Decrease in Pellino‐1 Expression Contributes to Osteoclast‐Mediated Bone Loss},
journal = {Advanced Biology},
year = {2024},
doi = {10.1002/adbi.202400210}
}
EUVIMED